Mohan P. Joshi

Scopus Publications

Fostering Local Ownership of Infection Prevention and Control Strategies: A Multi-country Program
Nicole C. McCann, Jeanette L. Kaiser, Nancy A. Scott, Tamara Hafner, Andre Zagorski, Mohan P. Joshi, Fozo Alombah, Allison Juntunen Morgan, José Antonio Requejo Domínguez, Veronika J. Wirtz
Annals of Global Health, 2026
Background: The United States Agency for International Development Medicines, Technologies, and Pharmaceutical Services (MTaPS) program supported partner countries to implement infection prevention and control (IPC)‑related programs. We evaluated the extent to which MTaPS‑supported IPC programs fostered local ownership, such that members of local or national‑level health systems had agency in developing and running programs. Methods: We surveyed three respondent groups involved in MTaPS IPC programs across eight African countries: (1) healthcare facility staff, (2) national‑level stakeholders, and (3) MTaPS‑contracted country implementers. Multiple‑choice survey questions asked respondents to rate the quality of collaboration and capacity‑building between their country and MTaPS, and the extent to which MTaPS fosters local ownership. Open‑response questions inquired about factors that did or did not foster local ownership. We described the proportion of respondents reporting each multiple‑choice response option, and conducted qualitative content analysis of open responses to generate themes about respondent perceptions of MTaPS support and local ownership. Results: We included 85 survey respondents: health facility staff (56%), MTaPS‑contracted country implementers (29%) and national‑level stakeholders (14%). Nearly all respondents rated the quality of MTaPS collaboration and capacity building “good” or “excellent.” Overall, 75%–92% of respondents rated the quality of MTaPS collaboration and capacity strengthening as “mostly” supportive of local ownership and 8%–25% rated it “sometimes,” supportive (0% selected “rarely/never”). Qualitatively, respondents described six activities as conducive to local ownership, including training, data collection/monitoring, stakeholder engagement, guideline/protocol standardization, creation/development of local committees, and supervision/mentorship/direct technical assistance. A reported barrier to MTaPS’ support of local ownership was the inconsistent implementation of activities. Conclusions: IPC programs should continue to prioritize strategies for fostering local ownership, particularly as the funding landscape shifts. To increase IPC program sustainability in advance of future infectious disease threats, additional resources are needed to scale up activities perceived as conducive to local ownership.
Multi-pronged system strengthening approach to improving infection prevention and control practices in Tanzania
Doris Lutkam, Niranjan Konduri, Joseph C. Hokororo, Eliudi S. Eliakimu, Fozo Alombah, et al.
Infection Prevention in Practice, 2025
To ensure the effectiveness of its infection prevention and control (IPC) programs, Tanzania recognised a need to revise IPC guidelines and standards; upgrade IPC training materials to address knowledge gaps among preservice health care students and health workers; improve IPC governance and practice at the national and health facility levels; and improve monitoring of IPC program performance and surveillance of healthcare associated infections (HAIs). Overall, our work addressed 20 out of 21 IPC-related actions in the World Health Organisation Benchmarks for International Health Regulations capacities tool between 2018 and 2024. Over a one-year period, we found that the percentage of patients developing surgical site infections remained at 1% on average in the 10 intervention hospitals, which is lower than the global average of around 2.5%. The Ministry of Health subsequently scaled up HAI surveillance to 69 additional hospitals. As a result, Tanzania achieved a score of 3 (developed capacity) for HAI surveillance specifically in the Joint External Evaluation conducted in August 2023. Building on this progress, the Ministry of Health will continue to scale up IPC programs in all public and private health facilities. Given the health security risks associated with Ebola, Marburg, Mpox, and other pathogens, significant efforts are needed to educate the public on the importance of practicing IPC measures to protect themselves from infectious diseases.
Antimicrobial use in a pediatric hospital in Kenya: a point prevalence survey to inform antimicrobial stewardship
Joseph Mbuthia, Nkatha Gitonga, Winnie Akoth, Susan Mutua, Ndinda Kusu, Tamara Hafner, Mohan P. Joshi, Martha Embrey
Frontiers in Tropical Diseases, 2025
IntroductionA baseline point prevalence survey (PPS) was conducted at Gertrude’s Children’s Hospital (GCH), a private pediatric hospital in Kenya, to assess antimicrobial use patterns, adherence to antimicrobial stewardship (AMS) protocols, and compliance with treatment guidelines. The survey aimed to provide insights into antimicrobial prescribing practices in a pediatric setting and address a critical gap in data from private healthcare facilities in Kenya.MethodsThe PPS included all inpatients as of 13 May 2022, excluding those discharged on that date, day cases, and those prescribed topical antimicrobials. Data were collected using a tool adapted from the World Health Organization (WHO) PPS standardized methodology, focusing on antimicrobial prescribing trends, compliance with GCH treatment guidelines, and adherence to WHO’s Access, Watch, and Reserve categorization.ResultsThe results showed that 61% of inpatients were on antimicrobials, with systemic antibacterials (J01) being the most prescribed, particularly third-generation cephalosporins, penicillin combinations, and imidazole derivatives. Ceftriaxone was the most commonly used antimicrobial, and the average number of antimicrobials prescribed per patient was 1.2. Prescribing practices showed a high use of Watch category antibiotics (51%) and a predominant use of the intravenous (IV) route (75%).DiscussionOnly 50% of prescriptions complied with guidelines and microbiological findings; we identified significant areas for improvement, including the need for structured reviews of antimicrobial prescriptions, better alignment with AMS objectives, and enhanced training on treatment guidelines, diagnostic stewardship, and infection prevention and control.ConclusionThe PPS provided valuable data to inform AMS interventions at GCH, the development of policies for IV-to-oral switch criteria, enhancement of the health management system, establishment of antimicrobial ward rounds, and improved education on laboratory result interpretation and appropriate sample collection.
Kenya’s National Action Plan on antimicrobial resistance: measuring implementation progress
Joseph Mukoko, Evelyn Wesangula, Nkatha Gitonga, Ndinda Kusu, Cynthia Odhiambo, Emmanuel Tanui, Allan Azegele, Romona Ndanyi, Mohan P. Joshi, Tamara Hafner, Niranjan Konduri
Frontiers in Tropical Diseases, 2025
Kenya has established a multisectoral national action plan (NAP) on antimicrobial resistance (AMR), which provides a common framework for action by all stakeholders from different sectors in implementing AMR containment activities. Monitoring and evaluation (M&amp;E) of the NAP-AMR has been weak, however, necessitating the development of a multisectoral M&amp;E framework in 2021. Using this M&amp;E tool, Kenya’s highest level technical body charged with containing AMR—the National Antimicrobial Stewardship Interagency Committee (NASIC)—led a review of the NAP-AMR (2017–2022) implementation progress at the national and county levels. The review showed that 16 out of 47 counties had established County Antimicrobial Stewardship Interagency Committees mirroring the NASIC and that 93% (38 out of 41) of the activities listed in the NAP-AMR (2017–2022) and the 2021 M&amp;E framework for human health were either completed or ongoing (compared to 64% [28 out of 44] that were completed or ongoing in the animal and crop sectors). Key challenges identified for the implementation of the NAP-AMR included lack of adequate funding; difficulties in effective collaboration across and within relevant sectors; weak laboratory-clinical interface; erratic supply of laboratory reagents, equipment, and supplies leading to underutilization of microbiology laboratories; and poor internet connectivity at the various facilities negatively affecting transmission of AMR data to the national level. Major learnings and recommendations from the review—strengthening governance arrangements at the national and county level; costing of the NAP-AMR; and ramping up advocacy efforts to political leadership to gather further support for actions on AMR—were integrated into the next iteration of the NAP-AMR (2023–2027), which was released during the World AMR Awareness Week in November 2023. Strengthening the process for monitoring the implementation of the NAP-AMR and cascading that process to the subnational (county) level were identified as critical for a robust operationalization of NAP-AMR.
Integration of IPC/WASH critical conditions into quality of care and quality improvement tools and processes: Bangladesh case study
Martha Embrey, Shahnaz Parveen, Tamara Hafner, Hafijul Islam, Abu Zahid, Mohan P. Joshi
Antimicrobial Resistance and Infection Control, 2024
Unsafe patient care in hospitals, especially in low- and middle-income countries, is often caused by poor infection prevention and control (IPC) practices; insufficient support for water, sanitation, and hygiene (WASH); and inadequate waste management. We looked at the intersection of IPC, WASH, and the global initiative of improving health care quality, specifically around maternal and newborn care in Bangladesh health facilities. We identified 8 primary quality improvement and IPC/WASH policy and guideline documents in Bangladesh and analyzed their incorporation of 30 subconditions under 5 critical conditions: water; sanitation; hygiene; waste management/cleaning; and IPC supplies, guidelines, training, surveillance, and monitoring. To determine how Bangladesh health care workers implemented the policies, we interviewed 33 informants from 16 public and private facilities and the national level. Bangladesh's 8 primary guidance documents covered 55% of the 30 subconditions. Interviews showed that Bangladesh health facility staff generally rely on eight tools related to quality improvement (five); IPC (two); and supportive supervision (one) plus a robust supervision mechanism. The stakeholders identified a lack of human resources and environmental hygiene infrastructure and supplies as the main gaps in providing IPC/WASH services. We concluded that the Bangladesh government had produced substantial guidance on using quality improvement methods to improve health services. Our recommendations can help identify strategies to better integrate IPC/WASH in resources including standardizing guidelines and tools within one toolkit. Strategizing with stakeholders working on initiatives such as universal health coverage and patient safety to integrate IPC/WASH into quality improvement documents is a mutually reinforcing approach.
Behavioral Nudges to Encourage Appropriate Antimicrobial Use Among Health Professionals in Uganda
Allison Ross, Philip J. Meacham, J. P. Waswa, Mohan P. Joshi, Tamara Hafner, Sarah Godby, Courtney Johnson, Shilpa Londhe, Dorothy Aibo, Grace Kwikiriza, Hassan Kasujja, Reuben Kiggundu, Michelle Cho, Sarah Kovar, Freddy Eric Kitutu
Antibiotics, 2024
Background/Objectives: Antimicrobial resistance (AMR) is a global public health concern exacerbated by inappropriate antimicrobial prescribing practices, particularly in low-resource settings such as Uganda. The research aimed to develop a culturally sensitive behavioral intervention, leveraging a “nudge” strategy, to improve healthcare provider adherence to the 2016 Uganda Clinical Guidelines (UCG 2016) in five Ugandan hospitals. This intervention formed part of broader antimicrobial stewardship initiatives led by the United States Agency for International Development Medicines, Technologies, and Pharmaceutical Services Program. Methods: This study employed a mixed-methods approach, combining formative research and behavioral intervention. Guided by the Deloitte Behavioral Insights Framework, the research team conducted key informant interviews to identify prescribing barriers and motivators and developed three suitable behavioral interventions: perceived monitoring, ward leaderboards, and educational workshops. The study evaluated the interventions’ impact through point prevalence surveys (PPS), using the World Health Organization PPS methodology at three stages: pre-intervention, immediate post-intervention, and one-month post-intervention. Results: Key behavioral themes across individual, social, environmental, and organizational elements informed the intervention design and implementation. The behavioral intervention package increased antimicrobial prescription compliance with the UCG 2016 from 27% at baseline to 50% immediately post-intervention, though these effects diminished at one-month post-intervention. Conclusions: Our study addresses an existing gap in behavioral nudges-based operational research on antimicrobial prescribing in low- and middle-income countries. These results showed an immediate improvement in adherence to the UCG 2016 among healthcare providers in Ugandan hospitals, though the effect was attenuated at one-month follow-up. Despite the attenuation, behavior change presents a feasible, cost-effective, and sustainable approach to improving antimicrobial prescribing practices and addressing AMR.
WHO global research priorities for antimicrobial resistance in human health
Silvia Bertagnolio, Zlatina Dobreva, Chad M Centner, Ioana Diana Olaru, Daniele Donà, Stefano Burzo, Benedikt D Huttner, Antoine Chaillon, Nebiat Gebreselassie, Teodora Wi, Mateusz Hasso-Agopsowicz, Benedetta Allegranzi, Hatim Sati, Verica Ivanovska, Kavita U Kothari, Hanan H Balkhy, Alessandro Cassini, Raph L Hamers, Kitty Van Weezenbeek, David Aanensen, Alexandre Alanio, Ana Alastruey-Izquierdo, Tinsae Alemayehu, Majdi Al-Hasan, Karel Allegaert, Amal Saif Al-Maani, Jameela Al-Salman, Abeer Nizar Alshukairi, Afreenish Amir, Tanya Applegate, George F Araj, Marlen Arce Villalobos, Christine Årdal, Diane Ashiru-Oredope, Elizabeth A Ashley, François-Xavier Babin, Laura H Bachmann, Till Bachmann, Kate Susan Baker, Manica Balasegaram, Colleen Bamford, Fernando Baquero, Laura Isabel Barcelona, Quique Bassat, Matteo Bassetti, Sulagna Basu, Justin Beardsley, Grey Benoit Vásquez, James A Berkley, Anuj K Bhatnagar, Julia Bielicki, Julie Bines, Felix Bongomin, Robert A Bonomo, John S Bradley, Catriona Bradshaw, Ana Brett, Adrian Brink, Colin Brown, Jeremy Brown, Kirsty Buising, Carolee Carson, Anna Cristina Carvalho, Elio Castagnola, Marco Cavaleri, Michele Cecchini, Chishala Chabala, Richard E Chaisson, Arunaloke Chakrabarti, Clare Chandler, Sujith John Chandy, Esmita Charani, Lisa Chen, Francesca Chiara, Anuradha Chowdhary, Arlene Chua, Pem Chuki, Doo Ryeon Chun, Gavin Churchyard, Daniela Cirillo, Lauren Clack, Susan E Coffin, Jennifer Cohn, Michelle Cole, John Conly, Ben Cooper, Alejandra Corso, Sara E Cosgrove, Helen Cox, Charles L Daley, Saffiatou Darboe, Tom Darton, Gerry Davies, Viviana de Egea, Amela Dedeić-Ljubović, Miranda Deeves, Claudia Denkinger, Jo-Anne R Dillon, Angela Dramowski, Brian Eley, Susanna Maria Roberta Esposito, Sabiha Y Essack, Helmia Farida, Joveria Farooqi, Nicholas Feasey, Cecilia Ferreyra, Helen Fifer, Heather Finlayson, Mike Frick, Ana Cristina Gales, Luisa Galli, Sumanth Gandra, Jeffrey S Gerber, Christian Giske, Bruce Gordon, Nelesh Govender, Nathalie Guessennd, Ibrehima Guindo, Elmira Gurbanova, Amanda Gwee, Ferry Hagen, Stephan Harbarth, John Haze, Jutta Heim, Rene Hendriksen, Robert Simon Heyderman, Kathryn Elizabeth Holt, Martin Hönigl, Edward W Hook, William Hope, Heidi Hopkins, Gwenda Hughes, Ghada Ismail, Mohammad Iqbal Issack, Jan Jacobs, Dušan Jasovský, Fyeza Jehan, Antonieta Jimenez Pearson, Makoto Jones, Mohan P Joshi, Arti Kapil, Samuel Kariuki, Abhilasha Karkey, Gregory L Kearns, Karen Helena Keddy, Nina Khanna, Akiko Kitamura, Kaija-Leena Kolho, Dimitrios P Kontoyiannis, Anita Kotwani, Roman S Kozlov, Katharina Kranzer, Ranmini Kularatne, Monica M Lahra, Bradley J Langford, Rafael Laniado-Laborin, Joakim Larsson, Cornelia Lass-Flörl, Kirsty Le Doare, Hyukmin Lee, Fernanda Lessa, Anna S Levin, Direk Limmathurotsakul, Nilton Lincopan, Andrea Lo Vecchio, Rakesh Lodha, Mark Loeb, Yves Longtin, David Chien Lye, Asif Mujtaba Mahmud, Célia Manaia, Lenore Manderson, Ivana Mareković, Kalisvar Marimuthu, Irene Martin, Tapfumanei Mashe, Zeng Mei, Jacques F Meis, Flávio Augusto Lyra Tavares De Melo, Marc Mendelson, Angelica Espinosa Miranda, David Moore, Chantal Morel, Nyambura Moremi, Maria Luisa Moro, Francis Moussy, Stephen Mshana, Arno Mueller, Francis J Ndow, Mark Nicol, Andrew Nunn, Stephen Obaro, Christina W Obiero, Iruka N Okeke, Uduak Okomo, Tochi J Okwor, Rita Oladele, Sylvia Omulo, Pascale Ondoa, Juana Medarda Ortellado de Canese, Luis Ostrosky-Zeichner, Maria Clara Padoveze, Madhukar Pai, Benjamin Park, Julian Parkhill, Christopher M Parry, Rosanna Peeling, Luísa Maria Sobreira Vieira Peixe, Olga Perovic, Melinda M Pettigrew, Nicola Principi, Céline Pulcini, Nelly Puspandari, Timothy Rawson, Denasha Lavanya Reddy, Kessendri Reddy, Paulo Redner, Juan Luis Rodríguez Tudela, Jesús Rodríguez-Baño, Susan Rogers Van Katwyk, Emmanuel Roilides, Christine Rollier, Leslie Rollock, Jean-Baptiste Ronat, Etienne Ruppe, Manish Sadarangani, David Salisbury, Mounerou Salou, Luc Hervé Samison, Maurizio Sanguinetti, Massimo Sartelli, Natalie Schellack, Jeroen Schouten, Mitchell J Schwaber, Jeremiah Seni, Abiola Senok, William M Shafer, Sadia Shakoor, Donald Sheppard, Jong-Hee Shin, Sonia Sia, Dawn Sievert, Ishwar Singh, Rupak Singla, Robert Leo Skov, Olusegun O Soge, Rosanne Sprute, Arjun Srinivasan, Subasree Srinivasan, Arnfinn Sundsfjord, Evelina Tacconelli, Sabira Tahseen, Viroj Tangcharoensathien, Thomas Tängdén, Karin Thursky, Guy Thwaites, Renata Tigulini de Souza Peral, Deborah Tong, Hafsah Deepa Tootla, Constantinos Tsioutis, Katy M Turner, Paul Turner, Shaheed Vally Omar, Wendy WJ van de Sande, Susan van den Hof, Rogier van Doorn, Balaji Veeraraghavan, Paul Verweij, Retno Wahyuningsih, Hui Wang, Adilia Warris, Hillard Weinstock, Evelyn Wesangula, David Whiley, Peter J White, Phoebe Williams, Yonghong Xiao, Martin Yagui Moscoso, Hsu Li Yang, Sachiyo Yoshida, Yunsong Yu, Dorota Żabicka, Matteo Zignol
Lancet Microbe, 2024
The WHO research agenda for antimicrobial resistance (AMR) in human health has identified 40 research priorities to be addressed by the year 2030. These priorities focus on bacterial and fungal pathogens of crucial importance in addressing AMR, including drug-resistant pathogens causing tuberculosis. These research priorities encompass the entire people-centred journey, covering prevention, diagnosis, and treatment of antimicrobial-resistant infections, in addition to addressing the overarching knowledge gaps in AMR epidemiology, burden and drivers, policies and regulations, and awareness and education. The research priorities were identified through a multistage process, starting with a comprehensive scoping review of knowledge gaps, with expert inputs gathered through a survey and open call. The priority setting involved a rigorous modified Child Health and Nutrition Research Initiative approach, ensuring global representation and applicability of the findings. The ultimate goal of this research agenda is to encourage research and investment in the generation of evidence to better understand AMR dynamics and facilitate policy translation for reducing the burden and consequences of AMR.
A One Health approach to fight antimicrobial resistance in Uganda: Implementation experience, results, and lessons learned
Reuben Kiggundu, J.P. Waswa, Niranjan Konduri, Hassan Kasujja, Marion Murungi, Patrick Vudriko, Harriet Akello, Eric Lugada, Cecilia Muiva, Esther Were, Dinah Tjipura, Henry Kajumbula, Kate Kikule, Emmanuel Nfor, Mohan P. Joshi
Biosafety and Health, 2024
. The country remains prone to outbreaks, with more than 20 disease outbreaks reported in the past five years, including Ebola virus disease, Crimean-Congo haemorrhagic fever, Marburg haemorrhagic fever, measles, yellow fever, coronavirus disease 2019 (COVID-19), and cholera. Antimicrobial resistance (AMR) is an ongoing challenge. Uganda scored capacity level 3 on infection prevention and control (IPC) and antimicrobial stewardship (AMS) in the 2017 Joint External Evaluation (JEE) assessment. Identified gaps were being addressed after a self-assessment in 2021. This paper describes the technical assistance approaches provided to Uganda by the Medicines, Technologies, and Pharmaceutical Services Program, funded by the United States (U.S.) Agency for International Development, and implemented by Management Sciences for Health. The program, through a One Health approach, supported systematic capacity strengthening based on the JEE's capacity advancement framework for global health security, specifically relating to AMR. The program's interventions impacted 32 WHO benchmark actions (7 for AMR multisectoral coordination, 16 for IPC, and 9 for AMS), contributing to Uganda's strengthened GHSA capacity. Leveraging success built on the AMR platform, the program trained 745 health workers in IPC for the Ebola virus and provided support for simulation exercises by eight district IPC teams. The program also worked with the Ministry of Health to coordinate IPC for the COVID-19 response in five health regions, covering 45 districts and reaching 5,452 health workers at 858 health facilities.
Assessment of the implementation of antimicrobial stewardship programs in selected healthcare facilities in Kenya
Nkatha Gitonga, Mitchel Okumu, Oscar Agoro, Ndinda Kusu, Joseph Mukoko, Helen Wangai, Tamara Hafner, Mohan P. Joshi
Frontiers in Tropical Diseases, 2024
BackgroundAntimicrobial resistance (AMR) is a growing concern globally and is notably prevalent in Kenya. The World Health Organization (WHO) Global Action Plan (GAP) and the Kenya National Action Plan (NAP) on AMR emphasize the need for effective antimicrobial stewardship (AMS) programs to combat AMR. The USAID-funded Medicines, Technologies, and Pharmaceutical Services (MTaPS) program has supported AMS implementation in 20 healthcare facilities (HCFs) in Nyeri, Kisumu, Murang’a, and Kilifi counties since 2019, focusing on developing and operationalizing AMS programs based on national, WHO, and Centres for Disease Control and Prevention (CDC) guidelines. However, there is paucity of information on how the AMS programs have been implemented in Nyeri and Kisumu Counties. This study evaluates the progress in AMS program implementation in these two counties between 2019 and 2023.MethodsBaseline and follow up assessments were conducted using a 33-item AMS questionnaire adapted from the CDC’s Core Elements of Hospital Antibiotic Stewardship Programs (CEHASP) and WHO guidelines. The assessment evaluated 13 thematic areas.ResultsAMS implementation showed significant improvements, with Nyeri county increasing from 12% to 76% and Kisumu from 17% to 78%. Several elements achieved 100% implementation in both counties, including core governance structures, accountability, and medical expertise. Education programs reached 88% implementation in Kisumu and 100% in Nyeri. Leadership support improved from 0% to 54% in Nyeri and from 0% to 60% in Kisumu. However, tracking antimicrobial use (AMU) and AMR through process measures remained the lowest implemented element (33% in Kisumu, 19% in Nyeri). Other challenges included limited microbiology services affecting antibiogram production, inadequate monitoring of adherence to treatment guidelines (0-7% implementation), and suboptimal implementation of policies and guidelines (48-58%).ConclusionsThese findings suggest that the implementation of antimicrobial stewardship programs (ASP) in resource-limited settings can be successful, as evidenced by the improvements in core governance, accountability, and medical expertise observed in the selected healthcare facilities. However, critical gaps remain in tracking antimicrobial use and resistance and monitoring treatment guideline adherence. To strengthen ASPs, we recommend establishing standardized national protocols for tracking and monitoring, developing regional laboratory networks to improve microbiology services access, and implementing electronic health records systems.
An educational initiative aimed at increasing antimicrobial resistance awareness among school-going Jordanian youth
Basmah Qenab, Tahreer Aqel, Hanin Younis, Rahmeh AbuShweimeh, Anwaar Al Zghoul, Zaina Sweedan, Mohammad Omran, Mohan P. Joshi, Niranjan Konduri
Frontiers in Public Health, 2024
BackgroundThe World Health Organization (WHO) has recommended strategies and actions to enhance awareness and understanding of AMR. Gaps in AMR awareness remain in Jordan, particularly among the youth.AimTo describe our programmatic approach to AMR education across Jordanian governorates among school-aged children.MethodsOur approach depicts the development of comprehensive health messages, pilot and expansion phases in schools, and pre- and post-session knowledge assessments.Results2,700 students across 30 schools reached with AMR health messages. Gained knowledge was assessed in 932 students, revealing significant improvements in understanding the importance of consulting a doctor before taking antibiotics, the relationship between nutrition and immunity, the dangers of sharing medicines, and proper handwashing techniques. The average expenditure was approximately $8.55 per student.ConclusionThe intervention underscores the critical role of targeted educational initiatives in improving AMR awareness among youth, emphasizing the need for sustained and scalable approaches to combat AMR effectively.
Enhancing infection prevention and control through hand hygiene compliance in six Ugandan hospitals using quality improvement approaches
Hassan Kasujja, J. P. Waswa, Reuben Kiggundu, Marion Murungi, Grace Kwikiriza, Rony Bahatungire, Henry Kajumbula, Fozo Alombah, Mohan P. Joshi, Niranjan Konduri
Frontiers in Public Health, 2024
Optimizing prophylactic antibiotic use among surgery patients in Ethiopian hospitals
Getachew Alemkere, Hailu Tadeg, Workineh Getahun, Wendosen Shewarega, Asrat Agalu, Mohan P. Joshi, Niranjan Konduri
Journal of Infection and Public Health, 2023
Identifying and addressing challenges to antimicrobial use surveillance in the human health sector in low- and middle-income countries: experiences and lessons learned from Tanzania and Uganda
Reuben Kiggundu, Edgar Lusaya, Jeremiah Seni, J. P. Waswa, Francis Kakooza, Dinah Tjipura, Kate Kikule, Cecilia Muiva, Mohan P. Joshi, Andy Stergachis, Freddy Eric Kitutu, Niranjan Konduri
Antimicrobial Resistance and Infection Control, 2023
Antimicrobial consumption surveillance in Uganda: Results from an analysis of national import data for the human health sector, 2018–2021
Marion Murungi, Helen Byomire Ndagije, Reuben Kiggundu, Diana Nakitto Kesi, JP Waswa, Kalidi Rajab, Mark Barigye, Allan Serwanga, Leonard Manirakiza, Hassan Kasujja, Ddembe Kaweesi, Mohan P. Joshi, Juliet Namugambe, Niranjan Konduri
Journal of Infection and Public Health, 2023
What is the appropriate antimicrobial use surveillance tool at the health facility level for Uganda and other low- and middle-income countries?
JP Waswa, Reuben Kiggundu, Niranjan Konduri, Hassan Kasujja, Lynn Lieberman Lawry, Mohan P. Joshi
Journal of Global Antimicrobial Resistance, 2023
Development and evaluation of a continuous quality improvement programme for antimicrobial stewardship in six hospitals in Uganda
Reuben Kiggundu, JP Waswa, Hilma N Nakambale, Francis Kakooza, Hassan Kassuja, Marion Murungi, Harriet Akello, Seru Morries, Mohan P Joshi, Andy Stergachis, Niranjan Konduri
BMJ Open Quality, 2023
Addressing gaps in AMR awareness in the public: an evidence-based policy brief to guide school curriculum review in Uganda
JP Waswa, Reuben Kiggundu, Mohan P. Joshi, Joseph Mpagi, Hassan Kasujja, Marion Murungi, Henry Kajumbula, Esther Were, Dan Schwarz, Kamada Lwere, Niranjan Konduri
Frontiers in Public Health, 2023
Point Prevalence Survey of Antibiotic Use across 13 Hospitals in Uganda
Reuben Kiggundu, Rachel Wittenauer, JP Waswa, Hilma N. Nakambale, Freddy Eric Kitutu, Marion Murungi, Neville Okuna, Seru Morries, Lynn Lieberman Lawry, Mohan P. Joshi, Andy Stergachis, Niranjan Konduri
Antibiotics, 2022
Strengthening multisectoral coordination on antimicrobial resistance: a landscape analysis of efforts in 11 countries
Mohan P. Joshi, Tamara Hafner, Gloria Twesigye, Antoine Ndiaye, Reuben Kiggundu, Negussu Mekonnen, Ndinda Kusu, Safoura Berthé, Edgar Peter Lusaya, Alphonse Acho, Robert Tuala Tuala, Ayasha Siddiqua, Henri Kaboré, Soukeyna Sadiya Aidara, Javier Guzman
Journal of Pharmaceutical Policy and Practice, 2021
Multidisciplinary and multisectoral coalitions as catalysts for action against antimicrobial resistance: Implementation experiences at national and regional levels
Mohan P. Joshi, Chifumbe Chintu, Mirfin Mpundu, Dan Kibuule, Oliver Hazemba, Tenaw Andualem, Martha Embrey, Bayobuya Phulu, Heran Gerba
Global Public Health, 2018
Engaging the private sector to improve antimicrobial use in the community: Experience from accredited drug dispensing outlets in Tanzania
Richard Valimba, Jafary Liana, Mohan P Joshi, Edmund Rutta, Martha Embrey, Maganga Bundala, Bryceson Kibassa
Journal of Pharmaceutical Policy and Practice, 2014
Antimicrobial sensitivity patterns of cerebrospinal fluid (CSF) isolates in Namibia: Implications for empirical antibiotic treatment of meningitis
Assegid Mengistu, Johannes Gaeseb, Gottfried Uaaka, Christophine Ndjavera, Kennedy Kambyambya, Lazarus Indongo, Francis Kalemeera, Christopher Ntege, David Mabirizi, Mohan P Joshi, Evans Sagwa
Journal of Pharmaceutical Policy and Practice, 2013
Antibiotic dispensing by drug retailers in Kathmandu, Nepal
David A. Wachter, Mohan P. Joshi, Binaya Rimal
Tropical Medicine and International Health, 1999
Drug information service at Teaching Hospitals in developing countries
Indian Journal of Pharmacology, 1998
University hospital-based drug information service in a developing country
M. P. Joshi
European Journal of Clinical Pharmacology, 1997
Geriatric prescribing in the medical wards of a teaching hospital in Nepal
Mohan P. Joshi, Takao Sugimoto, Budiono Santoso
Pharmacoepidemiology and Drug Safety, 1997
A teaching hospital-based drug information service in Nepal
Mohan P Joshi
Tropical Doctor, 1997
Drug rationalization: Now for the hard part
World Health Forum, 1997
A problem-orientated pharmacotherapy package for undergraduate medical students
Mohan P. Joshi, P. T. Jayawickramarajah
Medical Teacher, 1996
Intravenous Chloramphenicol plus Penicillin versus Intramuscular Ceftriaxone for the Treatment of Pyogenic Meningitis in Nepalese Children
P R Sharma, R K Adhikari, M P Joshi, M Lal, T Chodon, B M Pokhrel, R S Shrestha, I B Shrestha
Tropical Doctor, 1996
Antibiotic usage in the surgical wards of the T.U. Teaching Hospital, Kathmandu
Journal of the Institute of Medicine, 1992
Study of antibacterial usage at the TU Teaching Hospital
Journal of the Institute of Medicine, 1991
Therapeutic drug monitoring
Journal of the Institute of Medicine, 1990
Anti-inflammatory studies of the extracts of Curcuma amada rhizome
Journal of the Institute of Medicine, 1989

Mohan P. Joshi

RESEARCH, TEACHING, or OTHER INTERESTS

Scopus Publications

RECENT SCHOLAR PUBLICATIONS

MOST CITED SCHOLAR PUBLICATIONS